Tc99mGlucoheptonateQualityChecker

Tc-99m Glucoheptonate Quality Checker

api RPH Tc-99m renal imaging nuclear medicine CSV→JSON URS & FS rule-based
Open selection

Utility description: Tc-99m Glucoheptonate Quality Checker

Tc-99m Glucoheptonate Quality Checker — Technetium-99m Glucoheptonate for kidney and brain imaging

ℹ️  Utility checks critical parameters of Tc-99m Glucoheptonate (GH):
    • Radiochemical purity (≥95%)
    • Free pertechnetate (≤5%)
    • Reduced/hydrolyzed technetium (≤5%)
    • pH (4.5-7.5), Aluminum (<5 ppm)
    • Stability (≤6 hours) — PRONE TO OXIDATION!

⚠️  CRITICAL: Glucoheptonate is less stable than DTPA or MAG3!
    Use after 6 hours leads to accumulation in liver and thyroid gland.
    Used for renal cortical scintigraphy (especially in pediatrics) and brain imaging.

Usage:
  Tc99mGlucoheptonateQualityChecker.exe                            → demo mode (console output)
  Tc99mGlucoheptonateQualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation,ActivityMBq

Example:
  TC99M-GH-2026-001,97.0,1.5,1.5,3.0,6.0,40.0,0,4.0,3.0,700.0

— WHY IS THIS NEEDED?
Technetium-99m Glucoheptonate (GH) is a unique dual-action radiopharmaceutical:
• 6.02-hour half-life, 140 keV gamma radiation.
• Mechanism: rapid glomerular filtration + slow binding to proximal tubules.
• Allows assessment of both kidney function (early phases) and cortical anatomy (late phases).
• Penetrates disrupted blood-brain barrier, making it useful for diagnosing brain tumors and abscesses.
• Often used in pediatrics due to favorable dosimetry.

⚠️  CRITICAL:
• Radiochemical purity ≥95% — GH complex is less robust than DTPA/MAG3 and dissociates more easily.
• Free pertechnetate ≤5% — accumulates in thyroid and stomach, masking pathology.
• Reduced technetium ≤5% — colloids are taken up by liver, creating background during kidney studies.
• Usage time ≤6 hours — CRITICAL PARAMETER! GH is subject to oxidation and transchelation faster than other agents. After 6 hours, RCP may drop sharply.
• pH 4.5-7.5 — necessary to prevent hydrolysis and ensure biocompatibility.
• Aluminum <5 ppm — excess Al³⁺ catalyzes GH complex decomposition.

Key features:
• Strict stability time control (6 hours vs 8-12 for other drugs).
• Check of all standard safety parameters (sterility, endotoxins, heavy metals).
• Suitability assessment for two types of studies (kidneys and brain).
• Compliance with Ph. Eur. monograph on Technetium (99mTc) gluconate/glucoheptonate.

Critical parameters:
• Radiochemical purity: ≥95.0%
• Free pertechnetate: ≤5.0%
• Reduced technetium: ≤5.0%
• Aluminum oxide: <5.0 ppm
• pH: 4.5–7.5
• Endotoxins: <175 EU/mL
• Sterility: no growth
• Heavy metals: ≤10 ppm
• Stability time: ≤6 hours
• Minimum activity: ≥200 MBq

💡 Usage tips:
1. Prepare the drug immediately before use, avoid prolonged storage.
2. Do not use the drug if it has changed color or become turbid (sign of Sn²⁺ oxidation).
3. Brain studies require higher doses, so check activity carefully.
4. If RCP <95%, use only for qualitative assessment, not quantitative.
5. Store the kit in the refrigerator and protect from light to extend lyophilizate shelf life.

⚠️ Note: Tc-99m GH occupies a niche between purely filtration (DTPA) and purely secretory (MAG3) drugs. Its ability to fixate in the renal cortex allows obtaining excellent static images, but this feature requires impeccable radiochemical purity, as free technetium can also weakly bind to tissues, distorting the picture.

input.csv

BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation,ActivityMBq
TC99M-GH-2026-001,97.0,1.5,1.5,3.0,6.0,40.0,0,4.0,3.0,700.0
TC99M-GH-2026-002,94.0,4.0,2.0,4.5,6.5,80.0,0,6.0,5.5,500.0
TC99M-GH-2026-003,88.0,7.0,5.0,6.0,7.8,200.0,1,12.0,7.0,150.0

URS & FS — user requirements and functional specification

URS — User Requirements Specification

  • The utility shall accept input.csv with the headers defined by the data contract.
  • Before calculation, the utility shall detect missing fields, type errors and invalid values.
  • The utility shall deterministically perform “Tc-99m Glucoheptonate Quality Checker”.
  • The checks shall include the following criteria: Radiochemical purity: ≥95.0%; Free pertechnetate: ≤5.0%; Reduced technetium: ≤5.0%; Aluminum oxide: <5.0 ppm; pH: 4.5–7.5; Endotoxins: <175 EU/mL; Sterility: no growth; Heavy metals: ≤10 ppm; Stability time: ≤6 hours; Minimum activity: ≥200 MBq.
  • Each processed record shall receive a clear PASS, WARNING or FAIL status with the reason.
  • The result shall be written to output.json and retain the source values used for the checks.
  • The result supports batch-data review; release remains with authorised QA/QC personnel.

FS — Functional Specification

  1. Run Tc99mGlucoheptonateQualityChecker.exe in demo mode or with input.csv output.json arguments.
  2. Read UTF-8 CSV and validate the header and mandatory columns.
  3. Convert values to the expected types and validate admissibility.
  4. Perform the calculation or rule checks for “Tc-99m Glucoheptonate Quality Checker”.
  5. Create individual check results and the overall status.
  6. Write machine-readable JSON; invalid input shall not appear as a successful result.

input.csv example

BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation,ActivityMBq
TC99M-GH-2026-001,97.0,1.5,1.5,3.0,6.0,40.0,0,4.0,3.0,700.0

Minimum output.json structure

{
  "utility": "Tc99mGlucoheptonateQualityChecker",
  "source": "input.csv",
  "status": "PASS|WARNING|FAIL",
  "checks": [
    {
      "parameter": "example",
      "status": "PASS",
      "message": "criterion satisfied"
    }
  ],
  "errors": []
}

Before operational use

  • Limits and coefficients shall be approved before operational use.
  • After an executable or rule change, repeat the affected tests.
  • Retain the source CSV and JSON result together in the controlled process.

Included in packages

Radiopharmaceutical Diagnostics and Therapy QC Suite

36 utilities for clinically oriented radiopharmaceutical and workflow quality control: PET/SPECT tracers, the Tc-99m renal workflow, PRRT, PSMA therapy, targeted alpha therapy, radioembolization, bone-pain palliation, immuno-PET and generator-based radionuclide control.

Open

RPH isotope family: Tc-99m

Tc-99m radiopharmaceuticals, kit preparation, generator control, SPECT workflows and calculation utilities.

Open

RPH organ/system: brain and CNS

Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.

Open

RPH organ/system: endocrine, thyroid and NET

Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.

Open

RPH organ/system: hepatobiliary and GI

HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH organ/system: renal and urinary

Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.

Open

RPH Tc-99m Renal Radiopharmaceutical and Imaging QC Suite

16 utilities covering the Tc-99m renal workflow: generator eluate and Mo-99 breakthrough, Sn(II), labeling stoichiometry and pH, radiochemical purity and stability of MAG3, DTPA, DMSA(III) and glucoheptonate, gamma-camera uniformity, renal uptake and plasma clearance, bladder voiding efficiency, patient dosimetry and decay-in-storage waste management.

Open

RPH use case: Tc-99m renal and nephrourology

Renal radiopharmaceuticals and calculation workflows: MAG3, DTPA, DMSA, glucoheptonate, generator Tc-99m, dynamic renography, GFR/ERPF and dosimetry.

Open

RPH workflow: dosimetry and therapy planning

Activity planning, absorbed dose, organ dose, lung shunt, preplanning and therapy verification.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH workflow: synthesis, labelling and kit reconstitution

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Open